Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2025-10-30

FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for haloperidol decanoate submitted by Patriot Pharmaceuticals LLC, resulting in a label update for the long-acting inje…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL DECANOATE (Haloperidol decanoate)

Snippet

SUPPL AP for HALOPERIDOL DECANOATE (HALOPERIDOL DECANOATE)